Sangamo Therapeutics, Inc. - SGMO

About Gravity Analytica
Recent News
- 09.04.2025 - Wells Fargo Health Care Conference
- 09.03.2025 - Cantor Global Healthcare Conference
- 06.17.2025 - H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
- 06.12.2025 - Dapirolizumab Pegol Phase 3 Data in SLE Presented at the Annual European Congress of Rheumatology (EULAR) Show Improvement in Fatigue and Reduction in Disease Activity
- 06.04.2025 - Jefferies Global Healthcare Conference
- 06.04.2025 - Jefferies Global Healthcare Conference
- 05.27.2025 - Biogen and City Therapeutics Announce Strategic Research Collaboration to Develop Select Novel RNAi-based Therapies
- 05.20.2025 - H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ
- 05.20.2025 - H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ
- 05.13.2025 - May 13, 2025 - May 17, 2025 : ASGCT Annual Meeting 2025
Recent Filings
- 05.28.2025 - 4 Statement of changes in beneficial ownership of securities
- 05.28.2025 - 4 Statement of changes in beneficial ownership of securities
- 05.28.2025 - 4 Statement of changes in beneficial ownership of securities
- 05.28.2025 - 4 Statement of changes in beneficial ownership of securities
- 05.28.2025 - 4 Statement of changes in beneficial ownership of securities
- 05.13.2025 - 8-K Current report
- 05.13.2025 - 424B5 Prospectus [Rule 424(b)(5)]
- 05.13.2025 - FWP Filing under Securities Act Rules 163/433 of free writing prospectuses